Organon & Co.

For the period ended Dec 31, 2025. Filed Feb 24, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 24, 2026

OGN$13.89+0.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 8. Financial Statements and Supplementary Data

-57-

Item 8. Financial Statements

Index to the Consolidated Financial Statements	Page
Report of Independent Registered Public Accounting Firm (PCAOB ID 238)	59
Consolidated Statements of Income	62
Consolidated Statements of Comprehensive Income	63
Consolidated Balance Sheets	64
Consolidated Statements of Stockholders’ Equity	65
Consolidated Statements of Cash Flows	66
Notes to Consolidated Financial Statements	67
1.Background and Nature of Operations	67
2.Summary of Accounting Policies	67
3.Acquisitions and Licensing Arrangements	73
4.Earnings per Share	78
5.Product and Geographic Information	79
6.Stock-Based Compensation Plans	80
7.Restructuring	82
8.Taxes on Income	83
9.Inventories	87
10.Property, Plant and Equipment	88
11.Intangibles and Goodwill	88
12.Long-Term Debt, Short-Term Borrowings and Leases	90
13.Financial Instruments	94
14.Pension and Other Postretirement Benefit Plans	96
15.Accumulated Other Comprehensive Income (Loss)	100
16.Samsung Collaboration	100
17.Third-Party Arrangements	101
18.Contingencies	102
19.Subsequent Events	105

-58-

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.